Prevalence of Amyloid PET Positivity in Dementia Syndromes
Rik Ossenkoppele(Malmö University), David J. Brooks(Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas), Gaël Chételat(Inserm), Christopher C. Rowe(The University of Melbourne), Catherine M. Roe(Boston Children's Hospital), Ann D. Cohen(University of Pittsburgh), Philip Scheltens(Amsterdam University Medical Centers), Pieter Jelle Visser(Karolinska Institutet), Wiesje M. van der Flier(Amsterdam Neuroscience), Marie Sarazin(Université Paris Cité), Andrew B. Newberg(Thomas Jefferson University), Henryk Barthel(Leipzig University), William E. Klunk(University of Pittsburgh), Sander C.J. Verfaillie(Amsterdam UMC Location VUmc), Osama Sabri(Leipzig University), Stefan Förster(German Center for Neurodegenerative Diseases), Philipp T. Meyer(University of Freiburg), Kristian Steen Frederiksen(University of Copenhagen), David A. Wolk(University of Pennsylvania), Bruce L. Miller(University of California, San Francisco), Bart N.M. van Berckel(Amsterdam Neuroscience), Gil D. Rabinovici(University of California, San Francisco), Cristian E. Leyton(Neuroscience Research Australia), Adam Fleisher(Banner Alzheimer’s Institute), Victor L. Villemagne(The University of Melbourne), William J. Jagust(Lawrence Berkeley National Laboratory), Frederik Barkhof(National Hospital for Neurology and Neurosurgery), Adriaan A. Lammertsma(University Medical Center Groningen), Dong Yeob Lee(Seoul National University), Pascual Sánchez‐Juan(Universidad de Cantabria), Rik Vandenberghe(Allen Institute for Brain Science), Howard J. Rosen, Mark A. Mintun(Washington University in St. Louis), Alexander Drzezga(Forschungszentrum Jülich), Willemijn J. Jansen(Maastricht University), Sang Won Seo(Sungkyunkwan University), Koen Van Laere(Universitair Ziekenhuis Leuven), Marissa D. Zwan(Amsterdam UMC Location VUmc), Vincent Camus(Université de Tours), Susan Landau(University of California, Berkeley), Juha O. Rinne(University of Turku), Agneta Nordberg(Karolinska Institutet), Sabine Hellwig(University Medical Center Freiburg), John R. Hodges(Neuroscience Research Australia), Timo Grimmer(TUM Klinikum), J.M. Carril(Marqués de Valdecilla University Hospital), Sofie M. Adriaanse(Amsterdam UMC Location VUmc), Norman Koglin(Piramal (Germany)), Dirk L. Knol(Amyloidosis Foundation), Vincent Mok(Chinese University of Hong Kong), Duk L. Na(Samsung Medical Center)
Cited by 668
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k